Literature DB >> 20456386

Epidemiology of urticaria: a representative cross-sectional population survey.

T Zuberbier1, M Balke, M Worm, G Edenharter, M Maurer.   

Abstract

AIM: To investigate the prevalence of urticaria with a focus on chronic urticaria (CU) in a general German population.
METHODS: A questionnaire survey was sent to a representative cross-sectional sample of 13,300 inhabitants of Berlin, Germany, of whom 4093 responded. All respondents who stated ever having had weals or angio-oedema (n=767) were interviewed by telephone. Any interviewees with recent symptoms (within the previous 3 years) were invited for personal investigation including allergy tests; double-blind, placebo-controlled food challenge tests; and quality of life (QOL) assessment. Reported prevalence rates were weighted with regard to age, gender and education so that they were representative of the total population of Berlin.
RESULTS: Lifetime prevalence rate of urticaria was 8.8% (95% CI 7.9-9.7%) for all types of urticaria. Lifetime prevalence for CU was 1.8% (95% CI 1.4-2.3%), and prevalence for the 12 months before assessment was 0.8% (95% CI 0.6-1.1%), and 70.3% were female. QOL was markedly reduced for people with CU. Unlike other allergic diseases, there was no increased risk associated with higher education or social status. Prick tests found sensitization of ≥ 1 for type 1 allergens in 39.1% of patients. These were related to comorbidities such as allergic rhinitis or oral allergy syndrome, but were never the underlying cause of CU, as proven by double-blind, placebo-controlled provocation tests.
CONCLUSION: Urticaria is a common disease with marked effects on QOL. The lifetime prevalence of 8.8% for urticaria must be regarded as a lower limit as it is based on conservative prevalence rate calculations, and under-reporting of previous disease can be expected in a questionnaire-based study.
© 2010 The Author(s). Journal compilation © 2010 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20456386     DOI: 10.1111/j.1365-2230.2010.03840.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  63 in total

Review 1.  [Classification and pathophysiology of angioedema].

Authors:  T Buttgereit; M Maurer
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

Review 2.  Chronic Urticaria: Comparisons of US, European, and Asian Guidelines.

Authors:  S Shahzad Mustafa; Mario Sánchez-Borges
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-24       Impact factor: 4.806

Review 3.  [Chronic urticaria in childhood : Rational diagnostics and treatment].

Authors:  H Ott
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

4.  The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study.

Authors:  Dana Tzur Bitan; Daniella Berzin; Arnon Cohen
Journal:  Arch Dermatol Res       Date:  2020-04-08       Impact factor: 3.017

5.  Management of chronic spontaneous urticaria in the elderly.

Authors:  Maria Teresa Ventura; Nicoletta Cassano; Paolo Romita; Michelangelo Vestita; Caterina Foti; Gino Antonio Vena
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

6.  Clinical impact of omalizumab in refractory chronic urticaria: One centre experience.

Authors:  Diana Deleanu; Irena Nedelea; Carina Petricau; Poliana Leru; Dinu Dumitrascu; Adriana Muntean
Journal:  Exp Ther Med       Date:  2019-10-24       Impact factor: 2.447

7.  [Chronic urticaria. Prevalence, course, prognostic factors and impact].

Authors:  K Weller; S Altrichter; E Ardelean; K Krause; M Magerl; M Metz; F Siebenhaar; M Maurer
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

8.  [Health care of chronic inflammatory skin diseases : Do affected individuals seek dermatological care?]

Authors:  M C Schielein; L Tizek; F Seifert; T Biedermann; A Zink
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

9.  Allergy in Irish adults: a survey of referrals and outcomes at a major centre.

Authors:  N P Conlon; A Abramovitch; G Murray; A O'Hanrahan; D Wallace; K Holohan; N Cleary; C Feighery; C Lee-Brennan
Journal:  Ir J Med Sci       Date:  2014-04-18       Impact factor: 1.568

Review 10.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Marcus Maurer; Kilian Eyerich; Stefanie Eyerich; Marta Ferrer; Jan Gutermuth; Karin Hartmann; Thilo Jakob; Alexander Kapp; Pavel Kolkhir; Désirée Larenas-Linnemann; Hae-Sim Park; Gunnar Pejler; Mario Sánchez-Borges; Knut Schäkel; Dagmar Simon; Hans-Uwe Simon; Karsten Weller; Torsten Zuberbier; Martin Metz
Journal:  Int Arch Allergy Immunol       Date:  2020-03-30       Impact factor: 2.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.